Serveur d'exploration Tocilizumab - Analysis (France)

Index « AbsEn.i » - tête de navigation
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Index : AbsEn.i

Pour accéder à une entrée :

Les termes de plus forte occurence

336patients
289arthritis
246rheumatoid
240disease
234tocilizumab
198treatment
185study
157title
156clinical
136anti
126sec
123therapy
108response
107inflammatory
107cell
107associated
105efficacy
100systemic
99these
99therapeutic
96review
92were
90safety
88effects
86treated
84drugs
83results
83interleukin
82diseases
80receptor
78cells
76tnf
76but
72studies
72may
71also
70data
69effect
68management
68activity
67patient
67factor
66other
66biological
66after
64antibody
63background
62role
61agents
60new
59risk
59factors
58well
58severe
57modifying
57inflammation
57first
56abatacept
55italic
54rituximab
54methotrexate
54literature
54antibodies
54analysis
53during
53drug
52report
52remission
52immune
52development
52chronic
51including
51however
51all
50tcz
50syndrome
50increased
49objective
49active
48years
48treatments
48evidence
47biologic
46related
46onset
46necrosis
46monoclonal
46induced
46cytokine
46case
46autoimmune
45reported
45recent
45objectives
45high
45both
44specific
44effective
43who
43still
43potential
43assess
42trial
42rheumatic
42pathogenesis
42early
42cases
41trials
41therapies
41levels
41idiopathic
41human
40phase
40par
40evaluate
40could
40activation
39refractory
39controlled
39compared
38term
38several
38low
38current
37than
37months
37european
37against
36tumor
36there
36systematic
36non
36long
36life
36different
36conventional
35most
35joint
35antirheumatic
35aimed
34practice
34inhibitors
34inadequate
34expression
34aim
34abstract
33type
33targeted
33protein
33key
33juvenile
33involved
33common
33adult
32significant
32large
32dose
32cohort
32biologics
32assessed
31year
31target
31over
31important
31here
31characterized
31arteritis
30through
30present
30mechanisms
30diagnosis
30describe
30cytokines
30combination
30cancer
29sclerosis
29rheumatology
29recommendations
29provide
29available
28thus
28targeting
28inhibitor
28function
28control
27understanding
27targets
27rare
27prospective
27possible
27mediated
27infection
27impact
27immunosuppressive
27french
27biotherapies
27approach
26treat
26tissue
26shown
26progression
26involvement
26introduction
26infliximab
26effectiveness
26bone
26acute
25various
25under
25three
25side
25score
25pathway
25outcome
25improvement
25group
25damage
25criteria
25adalimumab
24versus
24strategies
24significantly
24responses
24production
24primary
24population
24only
24observed
24moderate
24major
24identified
24had
24eular
24due
24demonstrated
24considered
24assessment
24adverse
23time
23those
23symptoms
23subcutaneous
23should
23regulatory
23real
23rate
23profile
23outcomes
23need
23markers
23many
23main
23international
23increase
23included
23improve
23giant
23findings
23children
23cardiovascular
23blood
22while
22showed
22randomized
22promising
22novel
22models
22higher
22future
22further
22care
22association
21therefore
21synthetic
21strategy
21polymyalgia
21monotherapy
21manifestations
21mainly
21macrophage
21leading
21investigate
21health
21following
21events
21complications
21better
21before
21because
20will
20whether
20sup
20serum
20serious
20rheumatica
20retrospective
20randomised
20pathways
20often
20mtx
20methods
20infections
20identify
20follow
20failure
20evaluated
20dmards
20approved
20alpha
19within
19weeks
19unknown
19tumour
19tolerance
19sustained
19since
19respectively
19reduced
19potentially
19placebo
19pathophysiology
19open
19number
19needed
19level
19intravenous
19frequency
19few
19especially
19each
19disorders
19defined
19currently
19changes
19blockade
19biomarkers
19baseline
19any
19alternative
19addition
18without
18when
18vasculitis
18second
18rheumatism
18recently
18receiving
18reactive
18published
18observational
18knowledge
18inhibition
18induce
18index
18fri
18established
18developed
18dependent
18corticosteroids
18controls
18conclusion
18action
18according
17week
17vitro
17survival
17status
17similar
17registry
17proteins
17predictive
17plus
17ongoing
17model
17line
17known
17joints
17information
17good
17glucocorticoids
17evaluation
17discuss
17determine
17benefit
17being
17anakinra
17although
17adults
16widely
16vascular
16remain
16relapsing
16provides
16part
16overall
16order
16multicenter
16moreover
16molecular
16league
16label
16humanized
16found
16every
16condition
16college
16cellular
16body
16blocking
16american
16advances
16able
15world
15vivo
15very
15useful
15update
15thu
15system
15show
15severity
15setting
15rapid
15pulmonary
15proinflammatory
15post
15performed
15particularly
15mass
15like
15kinase
15improved
15highly
15fever
15features
15experimental
15etanercept
15described
15decreased
15characteristics
15bdmards
15articular
15another
15age
15acr
14virus
14structural
14series
14research
14reports
14renal
14remains
14provided
14proposed
14pro
14particular
14now
14mice
14meta
14measured
14lung
14limited
14least
14last
14investigated
14infusion
14influence
14infectious
14help
14healthy
14growth
14functions
14four
14finally
14dmard
14discussed
14despite
14derived
14decrease
14das
14course
14corticosteroid
14context
14combined
14cause
14blockers
14article
13wide
13transplantation
13subjects
13sparing
13signaling
13short
13secondary
13relevant
13relationship
13receptors
13reactions
13purpose
13presence

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/explor/Tocilizumab.storage/TocilizumabV1/Data/France/Analysis/AbsEn.i.hfd| SxmlCut idx/l | grep ...  

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021